...
首页> 外文期刊>Oncogene >p16INK4A-silencing augments DNA damage-induced apoptosis in cervical cancer cells
【24h】

p16INK4A-silencing augments DNA damage-induced apoptosis in cervical cancer cells

机译:p16INK4A沉默增强宫颈癌细胞中DNA损伤诱导的凋亡

获取原文
   

获取外文期刊封面封底 >>

       

摘要

p16INK4A (p16) has been suggested to be an early biomarker for the detection of cervical cancer. However, its functional role in cervical cancer is not well characterized. In this study, we reported the consistent and significant upregulation of p16 in cervical cancer tissues when compared to both matched non-tumourous tissues of the same patient and normal cervical tissues from non-cancer patients. We have employed p16 small interfering RNA (siRNA) to dissect the role of p16 in cervical carcinogenesis. Although the silencing of p16 was accompanied by the upregulation of p53, p21 and RB in the p16 siRNA-transfected cells, no significant effect on cell cycle progression was observed. When the p16 siRNA-silenced cells were subjected to DNA damage stress including ultraviolet-irradiation and cisplatin treatments, a significantly higher percentage of apoptotic cells could be observed in the p16-siRNA silenced cells compared to control siRNA-treated cells. Moreover, induction of apoptosis was associated with the activation of p53 through phosphorylation, and this process, when studied by gene profiling experiments, involved both the intrinsic and extrinsic apoptotic pathways. The observation that silencing of p16 expression augments DNA damage-induced apoptosis in cervical cancer cells offers alternative strategies for anti-cancer therapies for human cervical cancer.
机译:p16INK4A(p16)被认为是检测宫颈癌的早期生物标志物。但是,其在宫颈癌中的功能作用尚未很好地表征。在这项研究中,我们报道了与相同患者的匹配非肿瘤组织和非癌症患者的正常宫颈组织相比,宫颈癌组织中p16的一致且显着上调。我们采用了p16小干扰RNA(siRNA)来分析p16在宫颈癌发生中的作用。尽管p16沉默伴随着p16 siRNA转染的细胞中p53,p21和RB的上调,但未观察到对细胞周期进程的显着影响。当对p16 siRNA沉默的细胞进行DNA损伤应激(包括紫外线照射和顺铂处理)时,与对照siRNA处理的细胞相比,在p16-siRNA沉默的细胞中可以观察到明显更高的凋亡细胞百分比。此外,凋亡的诱导与通过磷酸化激活p53有关,当通过基因谱分析实验进行研究时,该过程涉及内在和外在的凋亡途径。 p16表达的沉默会增强DNA损伤诱导的宫颈癌细胞凋亡的这一发现为人类宫颈癌的抗癌治疗提供了替代策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号